Davis Todd C (CIK 1392029) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy LGND (132 shares), Buy PTHS (35,445 shares), Buy PTHS (503 shares), Buy LGND (10,495 shares), Buy LGND (20,782 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 132 | $21,214 |
| 2026-06-15 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 35,445 | $985,534 |
| 2026-06-15 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 503 | $14,449 |
| 2026-03-27 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 10,495 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 20,782 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 8,178 | $1.5M |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 39,644 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 15,600 | $2.9M |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 2,039 | $374,829 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 4,255 | $782,197 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 2,805 | $515,643 |
| 2025-12-08 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Sell | 130 | $0 |
| 2025-07-03 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 1.5M | $15.0M |
| 2025-07-02 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 233 | $21,222 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 1,680 | $175,678 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 2,307 | $241,151 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 5,523 | $583,615 |
| 2025-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | Buy | 21,382 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06